Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1979 Jun;24(3):967–970. doi: 10.1128/iai.24.3.967-970.1979

Enhancement and suppression by actinomycin D of a Vero cell nontransmissible measles infection.

S H Winston, R Rustigian
PMCID: PMC414404  PMID: 468384

Abstract

The effect of low doses of actinomycin D on Vero cell nontransmissible measles infection produced after cocultivation with a HeLa subline with persistent defective infection by Edmonston measles virus was examined by pretreatment of Vero cells with the drug and treatment at 1, 4, and 7 days after Vero cell infection. Pretreatment enhanced focal formation of viral immunofluorescent Vero cell syncytia but did not induce synthesis of detectable amounts od cocultures suppressed syncytial formation, and treatment of 4- and 7-day-old cocultures had little, if any, effect on syncytial formation. Pretreatment also eliminated a transient resistance to homologous superinfection. A possible relation of these findings to the presence of a cell-associated viral inhibitor in the persistently infected HeLa cells is discussed.

Full text

PDF
967

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baron S., Dianzani F. General considerations of the interferon system. Tex Rep Biol Med. 1977;35:1–10. [PubMed] [Google Scholar]
  2. Blalock J. E., Baron S. The transfer of interferon-induced viral resistance between animal cells. Tex Rep Biol Med. 1977;35:307–315. [PubMed] [Google Scholar]
  3. Champe P. C., Strohl W. A., Schlesinger R. W. Demonstration of an adenovirus-inhibitory factor in adenovirus-induced hamster tumor cells. Virology. 1972 Nov;50(2):482–494. doi: 10.1016/0042-6822(72)90399-6. [DOI] [PubMed] [Google Scholar]
  4. Desmyter J., Rawls W. E., Melnick J. L. A human interferon that crosses the species line. Proc Natl Acad Sci U S A. 1968 Jan;59(1):69–76. doi: 10.1073/pnas.59.1.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gresser I., Bandu M. T., Brouty-boye D., Tovey M. Pronounced antiviral activity of human interferon on bovine and porcine cells. Nature. 1974 Oct 11;251(5475):543–545. doi: 10.1038/251543a0. [DOI] [PubMed] [Google Scholar]
  6. HELLER E. ENHANCEMENT OF CHIKUNGUNYA VIRUS REPLICATION AND INHIBITION OF INTERFERON PRODUCTION BY ACTINOMYCIN D. Virology. 1963 Dec;21:652–656. doi: 10.1016/0042-6822(63)90239-3. [DOI] [PubMed] [Google Scholar]
  7. Mirchamsy H., Rapp F. Role of interferon in replication of virulent and attenuated strains of measles virus. J Gen Virol. 1969 Jun;4(4):513–522. doi: 10.1099/0022-1317-4-4-513. [DOI] [PubMed] [Google Scholar]
  8. Rustigian R. Persistent infection of cells in culture by measles virus. I. Development and characteristics of HeLa sublines persistently infected with complete virus. J Bacteriol. 1966 Dec;92(6):1792–1804. doi: 10.1128/jb.92.6.1792-1804.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Rustigian R. Persistent infection of cells in culture by measles virus. II. Effect of measles antibody on persistently infected HeLa sublines and recovery of a HeLa clonal line persistently infected with incomplete virus. J Bacteriol. 1966 Dec;92(6):1805–1811. doi: 10.1128/jb.92.6.1805-1811.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rustigian R., Winston S. H., Darlington R. W. Variable infection of Vero cells and homologous interference after co-cultivation with HeLa cells with persistent defective infection by Edmonston measles virus. Infect Immun. 1979 Mar;23(3):775–786. doi: 10.1128/iai.23.3.775-786.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Sawicki S. G., Godman G. C. On the differential cytotoxicity of actinomycin D. J Cell Biol. 1971 Sep;50(3):746–761. doi: 10.1083/jcb.50.3.746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Sawicki S. G., Godman G. C. On the recovery of transcription after inhibition by actinomycin D. J Cell Biol. 1972 Nov;55(2):299–309. doi: 10.1083/jcb.55.2.299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Schluederberg A., Hendel R. C., Chavanich S. Actinomycin D; renewed RNA synthesis after removal from mammalian cells. Science. 1971 May 7;172(3983):577–579. doi: 10.1126/science.172.3983.577. [DOI] [PubMed] [Google Scholar]
  14. Tan Y. H., Armstrong J. A., Ke Y. H., Ho M. Regulation of cellular interferon production: enhancement by antimetabolites. Proc Natl Acad Sci U S A. 1970 Sep;67(1):464–471. doi: 10.1073/pnas.67.1.464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Taylor J. Inhibition of interferon action by actinomycin. Biochem Biophys Res Commun. 1964;14:447–451. doi: 10.1016/0006-291x(64)90084-1. [DOI] [PubMed] [Google Scholar]
  16. Winston S. H., Rustigian R., Bratt M. A. Persistent infection of cells in culture by measles virus. 3. Comparison of virus-specific RNA synthesized in primary persistent infection in HeLa cells. J Virol. 1973 Jun;11(6):926–932. doi: 10.1128/jvi.11.6.926-932.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wong K. T., Baron S., Levy H. B., Ward T. G. Dactinomycin: relative resistance of green monkey kidney cell cultures to its action. Proc Soc Exp Biol Med. 1967 May;125(1):65–67. doi: 10.3181/00379727-125-32014. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES